A pair of new studies finds no significant benefit of the antiviral drug nirmatrelvir-ritonavir (Paxlovid) in alleviating the symptoms of adult long-COVID patients or in preventing the development of the condition in adolescents.
Democratic attorneys general in 16 states led by New York and Massachusetts sued the Trump administration Friday over the cancellation of millions of dollars in National Institutes of Health (NIH) grants for medical research.